Janux Therapeutics Inc (JANX) — Financial Flexibility Index
Janux Therapeutics Inc (JANX) has a Financial Flexibility Index of -0.14x as of March 2026. Free cash flow of $-12.06 Million (operating CF $-12.34 Million minus capex $273.00K) represents 0% of total liabilities ($86.69 Million). Check JANX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Janux Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Janux Therapeutics Inc across 7 annual periods. See how liquid is Janux Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Janux Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Janux Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Janux Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.60x | $-81.19 Million | $-82.23 Million | $50.70 Million | ▼ -42.7% |
| 2024 | -1.12x | $-43.45 Million | $-43.81 Million | $38.73 Million | ▲ +17.0% |
| 2023 | -1.35x | $-48.73 Million | $-50.58 Million | $36.06 Million | ▼ -60.3% |
| 2022 | -0.84x | $-36.48 Million | $-42.92 Million | $43.27 Million | ▲ +26.6% |
| 2021 | -1.15x | $-15.49 Million | $-16.98 Million | $13.50 Million | ▼ -1126.9% |
| 2020 | -0.09x | $-2.89 Million | $-4.37 Million | $30.86 Million | ▲ +65.6% |
| 2019 | -0.27x | $-2.35 Million | $-3.83 Million | $8.62 Million | — |